(Q38182411)

30 August 2017

Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. (English)

1 reference

30 August 2017

0 references

Paulus Kirchhof

4

0 references

Harry J. G. M. Crijns

series ordinal

3

object named as

Harry J Crijns

1 reference

30 August 2017

Etienne Aliot

1

1 reference

PubMed ID

24469433

30 August 2017

Giovanni L Botto

series ordinal

2

1 reference

30 August 2017

26 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

16

1 reference

30 August 2017

6

1 reference

30 August 2017

787-796

1 reference

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

30 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life in atrial fibrillation: measurement tools and impact of interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life in patients with silent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

EuroQol: the current state of play

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Investigation of the Karnofsky Performance Status as a measure of quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Effects of the maze operation on health-related quality of life in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Exercise tolerance and quality of life in elderly patients with chronic atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

AV nodal ablation and pacemaker implantation improves hemodynamic function in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: effect on quality of life and exercise performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Randomized controlled trial of fixed rate versus rate responsive pacing after radiofrequency atrioventricular junction ablation: quality of life, ventricular refractoriness, and paced QT dispersion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular a

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial isolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Paroxysmal atrial fibrillation and health-related quality of life: the importance of keeping score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Depression, anxiety, and quality of life in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Amiodarone for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Association between cognitive impairment and atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Can we improve outcomes in AF patients by early therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Atrial remodeling and atrial fibrillation: mechanisms and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

Long-Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUT369

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUT369

1 reference

30 August 2017

1 reference

PubMed ID

24469433